n6 is proud to announce a strategic partnership with SeqCenter, who is launching a groundbreaking full-length 16S sequencing service at FEMS Micro. This collaboration leverages n6’s iconPCR™ technology to empower researchers with superior data quality, reproducibility, and streamlined workflows, making advanced microbiome research accessible to all. n6 is excited to support SeqCenter in setting a new standard for microbiome analysis and to showcase the transformative potential of iconPCR in next-generation sequencing.
Also Read: LG Unveils Next-Gen Precision Medical AI
Why This Partnership Matters for Researchers
- Reduced Chimeras, Minimized Bias: iconPCR dramatically reduces chimeric sequences and amplification bias, delivering results that accurately reflect the microbial landscape of every sample.
- Full-Length 16S Resolution: Leveraging PacBio long-read sequencing, SeqCenter now offers species- and strain-level taxonomic resolution, far surpassing short-read methods.
- Consistent, Reproducible Results: Studies show iconPCR-prepared libraries retain more high-confidence reads, detect up to 10× more unique amplicon sequence variants (ASVs), and achieve tighter clustering in diversity analyses, demonstrating robust and reliable performance.
- Automated, Streamlined Workflow: With automated normalization and pooling, researchers simply send samples and receive actionable insights, reducing hands-on time and minimizing manual errors.
- Turnkey Solution: SeqCenter manages the entire process, from sample intake to comprehensive analysis, making advanced microbiome profiling accessible to all researchers.
A Partnership for All NGS Workflows
The n6 and SeqCenter collaboration is not limited to full-length 16S sequencing. Any next-generation sequencing (NGS) workflow where data quality is paramount can benefit from iconPCR’s transformative capabilities—including metagenomics, environmental, clinical, and industrial applications.
Source: PRNewswire